In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap forward in the field of cancer treatment. T3 Pharma boasts a cutting-edge therapy platform utilizing live bacteria to deliver […]
In a transaction that echoes the essence of refined heritage, Gérard and Nadia Dominicé have gracefully secured ownership of seven parcels in the picturesque commune of Genthod, nestled within the canton of Geneva. This
Waterland Private Equity, along with the minority stakeholders of Netrics Holding, has formalized a share purchase agreement for the divestment of all shares in Netrics Group to Bregal Unternehmerkapital, a global private equity firm. Netrics
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
bitvoodoo and Communardo Group have combined their businesses to further expand their solutions footprint across Germany, Austria and Switzerland. The two Atlassian Platinum Solution Partners are merging under the umbrella of the Communardo Group. Both
Man Group, a UK-based worldwide investment management company, has just completed its acquisition of a 51% participation in Asteria Investment Managers, a Geneva-based, ESG-oriented asset manager, from the Italian private bank Fideuram – Intesa Sanpaolo Private Banking.
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
The insurer AXA has acquired the successful Swiss fleet manager CarNet. AXA intends to gradually integrate CarNet Management into its subsidiary for mobil
Over the past years, Capture Media has played a significant role in shaping the landscape of Engagement Advertising in Switzerland, becoming an essential quality factor for many online campaigns. The company has also introduced fusedeck,
